NP / PA
Roberts, Emmie Lou
Roberts, Emmie Lou was paid $206K by Medicaid between Apr 2021 and Jul 2022, across 10 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 38% of everything it billed.
33Billing provider infoROBERTS, EMMIE LOU
PAWTUCKET, RI 02860
PAWTUCKET, RI 02860
33aNPI1083275325assigned 06/26/2019
33bProvider typeMedical Physician Assistant
28Total paid$206K
24GClaims2,230
24DCodes billed10
24AFirst – last monthApr 2021 – Jul 2022
Compared with peers
Next to other Medical Physician Assistant providers in Rhode Island
Rank by total paid#6 of 54
Median peer was paid$20K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 1,391 | $131K | |
| 2022 | 839 | $75K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 38% | 556 | 375 | $77K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 530 | 391 | $50K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 21% | 325 | 323 | $44K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.3% | 312 | 234 | $13K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.8% | 126 | 124 | $10K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 4.3% | 246 | 246 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 92 | 72 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 12 | 12 | $261.24 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 15 | 15 | $207.96 |
| 81025 | <1% | 16 | 12 | $189.04 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.